Balance Sheet

Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortization of Goodwill Amortization of Goodwill Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased

Daily Values

Growth Metrics

Ekso Bionics Holdings (EKSO) Amortizatization of Intangibles (2017 - 2023)

Ekso Bionics Holdings has reported Amortizatization of Intangibles over the past 6 years, most recently at $82000.0 for Q3 2023.

On a quarterly basis, Amortizatization of Intangibles rose 8100.0% to $82000.0 in Q3 2023 year-over-year; TTM through Sep 2023 was $196000.0, a 50.77% increase, with the full-year FY2018 number at $152000.0, down 15.08% from a year prior.
Amortizatization of Intangibles reached $82000.0 in Q3 2023 per EKSO's latest filing, up from $1000.0 in the prior quarter.
The five-year high for Amortizatization of Intangibles was $82000.0 in Q3 2023, with the low at $1000.0 in Q3 2022.